volociximab
A chimeric monoclonal antibody with potential antineoplastic activity. Volociximab binds to and inhibits the activity of alpha(5)beta(1) integrin, thereby inhibiting endothelial cell-cell interactions, endothelial cell-matrix interactions, and angiogenesis.
| Synonym: | anti-alpha 5 beta 1 integrin monoclonal antibody anti-α5β1 integrin |
|---|---|
| Abbreviation: | anti-α5β1 integrin MOAB |
| Code name: | M200 |